opening statement
We need a full panoply of investment in the research, the basic science, the drug discovery and drug development that la...
The goal of the biopharmaceutical accelerator will be in collaboration with our partners at NIAID.
The bacterium's resistance to colistin is particularly concerning because in this country physicians use colistin as the...
I wish you would, thanks, because maybe that can help illuminate--yes, Dr. Hatchett?
We have been worried for quite some time here in Congress and at the agencies about the risk of resistant antibiotics.
the instability in the market is I don't think unexpected.
Medicare is stronger now after the Affordable Care Act.
I worry that the bills that are under discussion today will actually increase costs and also harm access to insurance.
1.7 million Floridians now have been able to access affordable coverage.
myself and Congressman Bilirakis have introduced a bill that talks about lowering drug costs through competition.